Form 4 holding
Director
Maze Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 307,956
- Estimated value
- Report date
- 03 Feb 2025
- Price
- Ownership
- City Hill, LLC
Jonathan E. Lim - Director at Maze Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- MAZE on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Jonathan E. Lim since 23 Aug 2025
Reported holdings for Jonathan E. Lim in Maze Therapeutics, Inc.
Form 4 holding
Director
Maze Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 20,744
- Estimated value
- Report date
- 03 Feb 2025
- Price
- Ownership
- Direct
Form 4 holding
Director
Maze Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 18,000
- Estimated value
- Report date
- 08 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Maze Therapeutics, Inc.
- Security class
- Series A Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 03 Feb 2025
- Price
- Ownership
- City Hill, LLC
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Maze Therapeutics, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 03 Feb 2025
- Price
- Ownership
- City Hill, LLC
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Jonathan E. Lim in Maze Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.